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Animals that naturally acquire the prion diseases have a well-developed olfactory sense that they utilize
for a variety of basic behaviors. To assess the potential for the nasal cavity to serve as a point of entry for
prion diseases, a small amount of prion-infected brain homogenate was placed inferior to the nostrils of
hamsters, where it was immediately sniffed into the nasal cavity. Hamsters extranasally inoculated with
the HY strain of transmissible mink encephalopathy (TME) agent had an incubation period that was not
significantly different from per os inoculation of the same dose of the HY TME agent. However, the
efficiency of the nasal route of inoculation was determined to be 10 to 100 times greater based on endpoint
dilution analysis. Immunohistochemistry on tissues from hamsters killed at 2-week intervals after inoc-
ulation was used to identify the disease-associated form of the prion protein (PrPd) to determine the route
of prion neuroinvasion. Nasal mucosa-associated lymphoid tissue and submandibular lymph nodes ini-
tially accumulated PrPd as early as 4 weeks postinfection. PrPd was first identified in cervical lymph nodes
at 8 weeks, in the mesenteric lymph nodes, spleen, and Peyer’s patches at 14 weeks, and in the tongue 20
weeks after inoculation. Surprisingly, there was no evidence of PrPd in olfactory epithelium or olfactory
nerve fascicles at any time after inoculation. Therefore, the HY TME agent did not enter the central
nervous system via the olfactory nerve; instead, PrPd accumulated in elements of the cranial lymphore-
ticular system prior to neuroinvasion.
The prion diseases, or transmissible spongiform encephalop-
athies (TSEs), are a group of fatal neurodegenerative diseases
that affect animals, including humans. These neurodegenera-
tive diseases are notable for their ability to be transmitted from
one animal to another and for their relatively long incubation
periods. The natural route(s) of transmission have not been
determined. The route of transmission that has been studied
experimentally most extensively is the oral pathway. This
route is thought to be responsible for the transmission of
kuru, bovine spongiform encephalopathy (BSE), transmis-
sible mink encephalopathy (TME), and variant Creutzfeldt-
Jakob disease. Experimentally it has been shown that after
ingesting food pellets containing infected brain homogenate
prions gain access to the central nervous system (CNS) via
the autonomic innervation of the gut (7, 27, 34, 36). The
prion agent is transported retrogradely to the thoracic spinal
cord and the medulla via the sympathetic and parasympa-
thetic nerves, respectively (36). Once the prion agent enters
the CNS, there is evidence that spread occurs via synapti-
cally linked neurons (3, 7, 43).
With the exception of BSE-contaminated meat and bone
meal thought to be responsible for the outbreak of BSE in the
United Kingdom (10) and the cannibalistic practices that
spread kuru (18), the source of the prion agent that naturally
spreads the TSE among the affected species is not known.
Prions have been found in the urine of mice with chronic
kidney infections, indicating that urine may be a vector for
the spread of prion diseases in some cases (45). Recently, it
was reported that infectious prions were found in the saliva
and blood of deer with chronic wasting disease, thus indi-
cating that these bodily fluids may be a source of infection in
the wild (33). Other potential sources of infectivity that have
varying levels of experimental support for their efficacy in-
clude placenta (42), decaying carcasses (39), and excreta
(39). A recent in vitro study reported that soil can bind
prions and maintain infectivity, thus potentially serving as a
prion reservoir (25).
Deer, elk, cattle, and sheep are susceptible to the TSE, and
each of these species has a well-developed olfactory system
that is used for reproductive purposes and to detect predators
and food. Thus, it is likely that the nasal cavity of these species
would be an initial site of contact with any material that har-
bors the infectious agent. We tested the hypothesis that the
nasal cavity is a site of entry and neuroinvasion for the prion
agent by placing a small amount of the hyper (HY) strain of
TME agent just inferior to the nostrils of hamsters and observ-
ing these animals for the onset of clinical signs. This route was
established to be more efficient for causing disease than oral
inoculation. Subsequently, we carried out a pathogenesis study
to identify the initial site(s) of deposition and subsequent
spread of the prion disease-associated isoform of the prion
protein (PrPd). Immunohistochemistry (IHC) was used to
identify PrPd in the nasal cavity, submandibular lymph nodes,
cervical lymph nodes, mesenteric lymph nodes, spleen, Peyer’s
patches, and tongue at 2-week intervals after extranasal (e.n.)
exposure to the inoculum.
MATERIALS AND METHODS
Animal care. All procedures involving animals were preapproved by the
Creighton University Institutional Animal Care and Use Committee and were
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done in accordance with the Guide for the Care and Use of Laboratory Animals
(41). Adult male golden Syrian hamsters were obtained from Harlan Sprague-
Dawley (Indianapolis, IN). Hamsters were group housed in standard cages with
access to food and water ad libitum.
Animal inoculations. For all inoculations 10 to 50 l of a 1% (wt/vol) brain
homogenate from either an HY TME-infected hamster (containing a 109.3 in-
tracerebral [i.c.] 50% lethal dose [LD50]/g) or an uninfected hamster was used.
Hamsters receiving e.n. inoculations were anesthetized with ketamine (120 mg/
kg) and xylazine (10 mg/kg) intraperitoneally, and 5 l of inoculum was placed
just inferior to each nostril, for a total of 10 l of inoculum per animal. By not
placing the pipette tip inside the nasal cavity the possibility of inadvertent
damage to the nasal mucosa with subsequent infection of blood was avoided. The
inoculum was observed to be immediately drawn into the nasal cavity after
ejection from the pipette. The hamsters were then placed supine until the
anesthesia wore off and they began to move, which took between 5 and 10 min.
Hamsters inoculated per os were deprived of food for 24 h prior to being given
a food pellet that contained 10 l of inoculum. For i.c. inoculations, hamsters
were anesthetized with isoflurane (Webster Veterinary, Kansas City, MO), and
50 l of inoculum was injected into the right hemisphere by using a 30-gauge
needle attached to a 1-ml tuberculin syringe.
Clinical diagnosis and calculation of incubation period. The incubation period
was calculated as the length of time in days between exposure to the infectious
agent and the onset of clinical signs. Hamsters were observed for the onset and
progression of clinical signs three times a week beginning 60 days after inocu-
lation. Clinical signs characteristic of HY TME include an unkempt coat, wad-
dling gait, hyperactive responses to a gentle puff of air or light touch, ataxia, and
body tremors.
Efficiency of the nasal route. The endpoint titration of HY TME by the e.n.,
per os, and i.c. routes was established by inoculating groups of five hamsters
with 10-fold serial dilutions of inoculum and determining the incubation
period and attack rate. The titer was calculated by using the method of Reed
and Muench. The efficiency of the e.n. route was compared to that of the i.c.
and per os routes.
IHC. Infected and mock-infected hamsters were anesthetized with isoflu-
rane and perfused transcardially with 50 ml of 0.01 M Dulbecco phosphate
buffered saline, followed by 75 ml of McLean’s paraformaldehyde-lysine-
periodate fixative in preparation for IHC to identify the prion protein. The following
tissues were immediately dissected and placed into paraformaldehyde-lysine-perio-
date for 4 to 5 h at room temperature: nasal cavity, the lymph nodes that drain
the nasal cavity (submandibular and deep cervical lymph nodes [40]), the
mesenteric lymph nodes, spleen, Peyer’s patches from the proximal jejunum,
and the tongue. The tissues, except for the nasal cavity, were embedded in
paraffin, cut at 7 m on a rotary microtome, and mounted onto glass slides.
The nasal cavity was placed in decalcifying solution at room temperature for
3 to 4 weeks prior to being embedded and cut at 5 m. Infected and mock-
infected tissues for each time point were processed at the same time, using
the same reagents. All tissue sections were deparaffinized and subjected to
antigen retrieval in formic acid (minimum 95%) for 10 min at room temper-
ature. All of the following steps were carried out at room temperature, and
all incubations were separated by two to three rinses with 0.05% Tween in
Tris-buffered saline. Endogenous peroxidase and nonspecific antibody bind-
ing were blocked by incubating the tissue sections in 0.3% H2O2-methanol for
20 min, followed by incubation in 10% normal horse serum for 30 min.
Visualization of the prion protein was carried out using the avidin-biotin
method. Incubation in mouse anti-prion protein monoclonal antibody (clone
3F4, 1:600; Chemicon, Temecula, CA) was carried out for 2 h at room
temperature, followed by incubation in biotinylated horse anti-mouse anti-
body (1:600; Vector Laboratories, Burlingame, CA) for 30 min. The sections
were placed in ABC solution (1:200; Vector Laboratories) for 20 min and
then reacted in a solution containing filtered 0.05% diaminobenzidine tetra-
TABLE 1. Summary of processed and analyzed tissue sections
Tissue type
Section
thickness
(m)
No. of adjacent
tissue sections
per slide
Sampling interval (m) of
tissue sections: Avg no. of tissue sections
analyzed per infected
animalbInfected
animalsa
Mock-infected
animals
Nasal cavity 5 2–4 200 400 74 (coronal), 34 (sagittal)
NALTc 5 2–4 40 100 52 (coronal), 15 (sagittal)
Lymph nodes 7 4–5 56 140 50 (S), 40 (C), 47 (M)
Spleen 7 4 56 140 63
Peyer’s patches 7 4 56 140 48
Tongue 7 4 252 504 60
a Maximum distance between tissue sections; the sampling frequency was usually higher so the distance between sections was less.
b For lymph nodes, the values are subdivided by submandibular (S), cervical (C), and mesenteric (M) lymph nodes.
c A subset of sections from the nasal cavity that contain NALT.
TABLE 2. HY TME inoculation of hamsters by the i.c., per os, and e.n. routesa
Brain inoculum
dilutionb
i.c. Per os e.n.
Incubation period
(days)
No. affected/no.
inoculated
Incubation period
(days)
No. affected/no.
inoculated
Incubation period
(days)
No. affected/no.
inoculated
101 ND ND 158  17 4/5 161  11 5/5
102 ND ND 165  10 2/5 187  39 5/5
103 ND ND 400 0/5 224  28 4/5c
104 ND ND ND ND 210 1/5
105 ND ND ND ND 400 0/5
106 98  2 5/5 ND ND 400 0/5
107 134  9 4/5 ND ND 400 0/5
108 192  54 3/5 ND ND 400 0/5
109 400 0/5 ND ND 400 0/5
Mock 400 0/5 400 0/5 400 0/5
Titer 109.3 103.7 105.5
a The titers (calculated by the method of Reed and Muench) for the i.c., per os, and e.n. routes are expressed as the LD50/g. Values are expressed as means  the
standard deviation. ND, not done.
b Fifty (i.c.) or ten (per os, e.n.) microliters of HY TME brain homogenate was inoculated into each hamster.
c Significantly greater attack rate compared to per os inoculation (P  0.03 Fisher exact test).
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chloride (Sigma, St. Louis, MO) with 0.0015% H2O2. This concentration of
H2O2 was empirically determined to maximize the contrast between immu-
noreactivity of the normal cellular form of the prion protein, PrPc, and the
abnormal disease-associated form, PrPd. The sections were counterstained
with hematoxylin, dehydrated through graded alcohols, and coverslipped with
Cytoseal-XYL (Richard Allan Scientific, Kalamazoo, MI). Control sections
were processed identically with either the primary or the secondary antibod-
ies omitted or with a mouse immunoglobulin G isotype control (Abcam,
Cambridge, MA) in place of the primary antibody at the same concentration.
When additional morphological detail was required, selected adjacent tissue
sections were stained with hematoxylin and eosin.
To determine the temporal and spatial spread of PrPd after exposure to the
nasal cavity, tissue sections were examined by using an Olympus BX-40 light
microscope and photographed using analySIS software (Soft Imaging System,
Lakewood, CO). The sampling frequency and total number of sections of the
various tissues that were processed and analyzed are summarized in Table 1.
For infected hamsters, regularly spaced tissue sections from the nasal cavity
spaced not more than 200 m apart were inspected for the presence of PrPd
immunoreactivity (PrPd-ir); for the portion of the nasal cavity that contained
the nasal mucosa-associated lymphoid tissue (NALT), the sampling fre-
quency was increased so that the inspected sections were not more than 40
m apart. For lymph nodes, spleens, and Peyer’s patches of infected ham-
sters, two to four serial sections spaced not more than 56 m apart were
processed and analyzed. The tongue was cut sagittally, and sections from
infected hamsters not further apart than 252 m apart were processed and
analyzed. For each tissue the initial time postinoculation of PrPd deposition
was established, as well as the time when all inoculated hamsters demon-
strated PrPd. Sections from each type of tissue were also processed at 22
weeks after inoculation to determine the pattern and extent of PrPd deposi-
tion close to the onset of clinical symptoms.
RESULTS
TME infection after e.n. exposure. The efficiency of the e.n.
and per os routes of HY TME infection were determined by
calculating the TME titer by endpoint dilution. Based on these
data, the LD50 values per gram of brain tissue were 10
5.5 for
the e.n. route, 103.7 for the per os route, and 109.3 for the i.c.
route. Thus, e.n. exposure was between 10 and 100 times more
efficient in transmitting disease than oral inoculation via a food
pellet. By comparison, the e.n. route was 1,000 to 10,000 times
less efficient in transmitting disease than direct i.c. inoculation
(Table 2).
Deposition and accumulation of PrPd in extraneural
structures. IHC was used to identify the initial site and time of
deposition and the subsequent temporal spread of PrPd after
e.n. inoculation of HY TME in hamsters that were killed at
2-week intervals after inoculation. The nasal cavity, the sub-
mandibular and cervical lymph nodes, the mesenteric lymph
nodes, the spleen, Peyer’s patches, and the tongue were exam-
ined for the presence of PrPd. The pattern of PrP-ir seen in
infected hamsters was compared to that of mock-infected ham-
sters processed identically (with the same reagents at the
same time) for each time point. Discrete, punctate deposits
of PrP-ir were seen in selected tissues in infected hamsters
but never in mock-infected hamsters and are referred to
here as PrPd (Fig. 1). Omission of either the primary or
secondary antibody or replacement of the primary antibody
with an isotype control resulted in a complete lack of stain-
ing on control sections (data not shown). A summary of the
temporal deposition of PrPd in peripheral tissues is shown in
Table 3.
Nasal cavity. Regularly spaced frontal or sagittal tissue sec-
tions from the entire extent of the nasal cavity from infected
and mock-infected hamsters killed at 2-week intervals after
inoculation were examined for the presence of PrPd. The lining
of the nasal cavity included olfactory, respiratory, and follicle-
associated epithelia that are attached to a lamina propria (Fig.
2). Immunoreactivity to the 3F4 antibody was restricted to
aggregations of lymphoid tissue in the lamina propria of the
FIG. 1. Deposition of PrPd in select tissues taken from infected
(A, C, E, G, and I) and mock-infected (B, D, F, H, and J) hamsters
at 22 weeks after e.n. inoculation. IHC using an antibody to the
prion protein was used to identify PrPd. Matched pairs of tissue
sections of the NALT (A and B; NALT outlined by dashed lines),
a follicle in the submandibular lymph (C and D; outer edge of
follicle outlined by dashed line), white pulp nodule of the spleen (E
and F), Peyer’s patch (G and H), and a fungiform papillae of the
tongue (I and J; base of taste bud outlined by dashed line) from
infected and mock-infected hamsters that were processed identi-
cally. Note the punctate deposits of PrPd that were seen only in
tissues of hamsters that were inoculated e.n. with HY TME and the
lack of PrPd in the same tissues taken from the e.n. mock-infected
hamsters. Bar, 50 m.
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floor of the nasal cavity at the entrance of the nasopharyngeal
duct (Fig. 2D). This unencapsulated lymphoid tissue was or-
ganized into follicles and has been designated by others as
NALT (31, 47, 51). There was no immunoreactivity in the
olfactory epithelium (Fig. 2B), the respiratory epithelium (Fig.
2C), or the vomeronasal organ (data not shown) in any ham-
ster, at any time point after inoculation. The only site of dis-
crete, punctate staining in the nasal cavity of infected hamsters
was in the NALT (Fig. 1A, 2D, and 3). Punctate, discrete
immunoreactivity was never seen in the NALT or in any of the
tissues examined from any of the mock-infected hamsters (Fig.
1B, 1D, 1F, 1H, and 1J).
There was no staining in the nasal cavity of infected ham-
sters 2 weeks after inoculation. Beginning at 4 weeks after
inoculation a few discrete, granular depositions of PrPd of
various size were visible in the NALT of all three infected
hamsters bilaterally (Table 3 and Fig. 3A). The immunore-
active accumulations were as large as 2 to 3 m in diameter
and appeared to be primarily located in the cytoplasm or on
the surface of relatively large, pale staining cells located
between lymphocytes (Fig. 3). We did not identify these
cells using any cell-specific markers but, based on their size,
location, and previous reports, the PrPd appeared to be
associated with macrophages and follicular dendritic cells
(1, 2, 28, 35, 46, 52). At every subsequent time point all three
of the infected hamsters had PrPd in the NALT, and the
amount of PrPd gradually increased in hamsters at later time
points postinfection (Fig. 3). In hamsters that survived 22
weeks after inoculation, the PrPd was located through the
entire rostral-caudal and medial-lateral extent of the NALT
(Fig. 3D).
Lymph nodes. PrPd was first noted in the follicles of sub-
mandibular lymph nodes of one of the three infected hamsters
4 weeks after inoculation. It was present in two of three in-
fected hamsters 6 weeks after inoculation and in all three
infected hamsters at all subsequent time points (Table 3). The
amount and pattern of deposition of PrPd was variable from
one hamster to the next within a group, but a gradual in-
crease in PrPd immunoreactivity over time was consistently
observed (Fig. 4A). Uninfected lymph nodes were present
among the infected lymph nodes, even at later time points,
and infected follicles within a given lymph node were some-
times, but not always, adjacent to one another (Fig. 4A).
Initially, PrPd was only noted in one follicle, but at later time
points the maximum number of PrPd-ir follicles in a single
lymph node increased to as many as 11. Just as in the NALT,
PrPd was always located between lymphocytes and appeared
to be associated with follicular dendritic cells and macro-
phages (1, 2, 28, 35, 46, 52). PrPd was first noted in the
cervical lymph nodes of one of the three infected hamsters
8 weeks after inoculation and was present in all three in-
fected hamsters at all subsequent time points (Table 3). The
deposition of PrPd within the cervical lymph nodes was
similar in appearance to that seen in submandibular lymph
nodes, but the amount of immunoreactivity was consistently
less (Fig. 4C), and PrPd did not accumulate in multiple
follicles over time. The maximum number of PrPd-ir follicles
seen in a cervical lymph node was six, which was seen in a
hamster at the earliest time point at which a cervical lymph
node was determined to be immunopositive. PrPd was first
noted in the mesenteric lymph nodes of two infected ham-
sters at 14 weeks after inoculation but was not seen in all
three infected hamsters till 20 weeks after inoculation (Ta-
ble 3). The number of PrPd-ir follicles and the amount
immunoreactivity per immunopositive follicle was much less
than what was noted in either the cervical or the subman-
dibular lymph nodes (Fig. 4E), but the location of PrPd was
the same between lymphocytes and in association with pre-
sumptive macrophages and follicular dendritic cells.
Spleen and Peyer’s patches. PrPd was first noted in white
pulp nodules of the spleen in two of three hamsters 14 weeks
after inoculation with HY TME (Table 3; Fig. 5A). It was
present in all three hamsters at 16 and 22 weeks after inocu-
lation. Although the number of immunopositive nodules in-
creased with time from inoculation, the maximum number
of PrPd-ir nodules on any section of spleen was five, which
represented less than half the number of nodules present.
The pattern of immunoreactivity was similar to what has
been reported previously in mice inoculated i.c. (24), with
staining predominantly in the germinal center of white pulp
nodules and less-frequent staining in the peripheral white
pulp. Although no additional markers were used to identify
specific cell types, the staining was clearly restricted to non-
lymphocytes (Fig. 5B). In Peyer’s patches PrPd was first
noted in one hamster 14 weeks after inoculation and in one
hamster at 16 weeks (Table 3). At 18 weeks, PrPd was seen
in the Peyer’s patches of two of the three infected hamsters
and in all three infected hamsters at 20 and 22 weeks after
inoculation (Fig. 5C). The deposition of PrPd in Peyer’s
patches was similar to what has been reported previously for
orally inoculated hamsters (6). PrPd was located between
lymphocytes and in, or on, large cells, presumably macro-
phages and/or follicular dendritic cells (Fig. 1G and 5D).
Although the majority of PrPd was located within the Pey-
TABLE 3. Temporal deposition of PrPd in extraneural structures after e.n. inoculation
Structure
No. of PrPd-positive hamsters/total no. of e.n.-inoculated hamsters at time point (in wk) postinoculation:
2 4 6 8 10 12 14 16 18 20 22
Nasal cavity: NALT 0/3 3/3 3/3 3/3 3/3 3/3 3/3 3/3 ND ND 3/3
Submandibular lymph node 0/3 1/3 2/3 3/3 3/3 3/3 3/3 3/3 ND ND 3/3
Cervical lymph node ND ND 0/3 1/3 3/3 2/2 3/3 3/3 ND ND 3/3
Mesenteric lymph node ND ND ND ND ND 0/3 2/3 1/3 1/3 3/3 3/3
Spleen ND ND ND ND 0/3 0/3 2/3 3/3 ND ND 3/3
Peyer’s patch ND ND ND ND ND 0/3 1/3 1/3 2/3 3/3 3/3
Tongue ND ND ND ND ND ND ND ND 0/3 1/3 2/3
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er’s patches, there was also intense staining in neurons of
nearby submucosal plexi in hamsters that had multiple Pey-
er’s patches labeled (not shown) and in the lamina propria
of the villi of several hamsters (not shown).
Tongue. PrPd was first noted in the tongues of one of three
hamsters at 20 weeks postinfection and two of three ham-
sters at 22 weeks postinfection. The staining was seen in a
small percentage (	10%) of fungiform papillae, often at the
FIG. 2. Hamster nasal cavity with the different types of covering epithelia and the NALT in the lamina propria in the floor of the nasal cavity.
(A) A low-power view of a hematoxylin-and-eosin-stained coronal section of half of the nasal cavity from a hamster shows the midline nasal septum,
the position of the NALT (indicated by arrows), the boundary between the olfactory and respiratory epithelia (dotted line), and the extent of the
follicle-associated epithelium overlying the NALT (asterisks). The olfactory epithelium lines the nasal cavity above the dotted line, while
respiratory epithelium lines most of the nasal cavity below the dotted line. The follicle-associated epithelium lines a small part of the nasal cavity
that overlies the NALT. Adjacent tissue sections from the areas indicated by boxes 1 to 3 in panel A from a hamster 6 weeks after e.n. inoculation
were processed for PrPd using IHC and shown at higher magnifications in panels B to D, respectively. Note the lack of PrPd in the olfactory
epithelium (B) and the respiratory epithelium (C) and the adjacent nerve fascicles in the lamina propria (arrows). (D) Punctate deposits of PrPd
were identified only in the NALT of hamsters inoculated with HY TME e.n. and not in any other structures. (E) Hematoxylin and eosin
staining of hamster NALT, view enlarged from the tissue section in panel A, reveals the morphology of the hamster NALT, which is made
up largely of lymphoid tissue. OE, olfactory epithelium; RE, respiratory epithelium; FAE, follicle-associated epithelium. Bars: A, 500 m;
B, C, D, and E, 50 m.
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base of taste buds, but also in the lamina propria and in a
small number of nerve fascicles on the dorsum or tip of the
tongue (Fig. 1I and J). PrPd was not seen in skeletal muscle
cells or in the stratified squamous epithelium of either the
dorsal or ventral surfaces of the tongue in any hamster.
DISCUSSION
Other than a brief mention of mice being infected intrana-
sally with scrapie agent in a 1963 publication (13), this is the
first report of prion infection after exposure of the agent to the
nasal cavity. All hamsters e.n. infected with a high dose of HY
TME brain homogenate became clinically ill with an incuba-
tion period similar to that of hamsters infected per os with the
same dose of HY TME agent. Of particular interest was the
finding that the nasal route was more efficient than the oral
route, based on the calculated LD50 per gram of tissue (Table
2). Thus, a smaller dose of agent introduced to a hamster via
the nasal cavity was more likely to result in disease than if a
food pellet containing the inoculum was ingested. However, we
cannot exclude the possibility that other modes of oral infec-
tion (e.g., direct application to oral mucosa) may change the
relative differences between these two routes of infection. This
route of infection may be of significance to the natural trans-
mission of disease, since animals that naturally develop the
TSE are olfactory driven and use their olfactory sense for a
variety of basic life activities such as securing food, detecting
predators, and reproduction. Therefore, they may expose their
nasal cavity to the infectious agent as they use their sense of
smell to explore their environment. The placement of the
agent just outside of the nasal cavity in the present study was
intentional so as to avoid any unintentional damage to the
epithelia that line the nasal cavity with the pipette tip, since
there are nerves and blood vessels located in the underlying
lamina propria that could unintentionally serve as a site of
entry for the agent.
PrPd was identified using IHC in the NALT of the nasal
cavity of all infected hamsters between 4 and 22 weeks postin-
fection, but not in the olfactory epithelium and nerve fascicles,
as we had hypothesized. There were several reasons to expect
that the olfactory nerve might serve as a route of entry for
prion infection after nasal cavity exposure, including the ex-
pression of PrPc by olfactory receptor neurons (17), which is
necessary for prion replication (8); the ability of olfactory re-
ceptor neurons to support prion replication (11, 54); and the
involvement of olfactory structures in chronic wasting disease
of deer and elk (48, 53). However, in the experiments reported
here none of the cells of the olfactory epithelium, 75 to 85% of
which are olfactory receptor neurons (14), and no associated
nerve fascicles, which include the axons of these neurons, ac-
cumulated any detectable amount of PrPd at any point after
exposure to the agent. Thus, the olfactory neurons were not
responsible for transporting prions into the CNS of these an-
imals. Instead, it appears that the neuroinvasion of this strain
of prion in this animal model is another example where the
agent initially accumulates in peripheral lymphoid tissue and is
subsequently transported to the CNS (recently reviewed in
reference 32).
The detection of PrPd in the NALT of all infected ham-
sters at 4 weeks after inoculation, which represents 14% of
the incubation period, is much earlier than the first detec-
tion of agent in the Peyer’s patches in the present study (14
weeks; 50% of the incubation period). This interval is also
FIG. 3. Progressive accumulation of PrPd in the NALT of hamsters inoculated with HY TME. (A to D) Tissue sections that include depositions
of PrPd in the NALT from hamsters at 4 weeks (A), 10 weeks (B), 16 weeks (C), and 22 weeks (D) after e.n. inoculation. Note the increased
amount of PrPd immunoreactivity in the NALT at the various times postinfection. There is an increase in both the number of punctate
deposits and the size of the deposits. The asterisk indicates the air space of the nasal cavity in each picture, and the arrow indicates a nerve
fascicle (C). Bars, 50 m.
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earlier than other reports of peripheral accumulation of the
agent in lymphoid tissue after per os inoculation of a similar
prion strain in hamsters (6). Whether this relatively early
and progressive accumulation of agent in lymphatic tissue
after a nontraumatic inoculation is responsible for the
greater efficiency of this route compared to the per os route
in this model of prion infection, or is just coincident, re-
mains to be determined.
The NALT in rodents are a component of the mucosa-
associated lymphoid tissue that includes bronchus-associated
lymphoid tissue and Peyer’s patches (31, 47). The NALT are
paired, unencapsulated lymphoid structures located in the
floor of the nasal cavity near the entrance to the pharynx that
are thought to be analogous to the tonsils and adenoids in
humans (29, 31). Rodent NALT is covered by a follicle-asso-
ciated epithelium that includes microfold cells (M cells) and
consists of follicles containing T cells, B cells, macrophages,
and follicular dendritic cells (19, 22, 30).
The temporal pattern of PrPd accumulation after e.n. expo-
sure is consistent with initial accumulation in the NALT, fol-
lowed quickly by spread to the draining submandibular lymph
nodes and then to the regional deep cervical lymph nodes.
From there the agent could enter the lymph and blood and
spread to distant lymph nodes and the spleen, since detection
of PrPd in these structures occurred 6 weeks later at 14 weeks
after inoculation. Alternatively, the agent may gain access to
the lymph nodes and blood via unknown non-NALT routes.
PrPd was detected in the Peyer’s patches of one of three
infected hamsters at 14 and 16 weeks after inoculation. These
time points represent 50 and 57% of the incubation period.
Given that neuroinvasion of the spinal cord and brain usually
occurs between 25 and 50% of the incubation period after
non-neural inoculation (26), the presence of PrPd in the Pey-
er’s patches at these and subsequent time points in the incu-
bation period of this route of infection suggests the spread of
the agent from the CNS to these structures, as opposed to
FIG. 4. PrPd in lymph nodes after e.n. inoculation. (A) Low-power view of PrPd in multiple follicles (indicated by arrows) of a submandibular
lymph node of a hamster 14 weeks after e.n. inoculation. (B) High-power view of the area outlined by the box in panel A. The PrPd is located in,
or on, cells and cell processes between the lymphocytes of the submandibular lymph node. (C) Low-power view of a cervical lymph node of a
hamster at 22 weeks postinoculation. Note the PrPd is found in only two follicles (box and arrow). (D) High-power view of PrPd in the area outlined
by the box in panel C. PrPd is located between the lymphocytes of the follicle. (E) Low-power view of a mesenteric lymph node of a hamster at
22 weeks postinoculation. Note that the PrPd is limited to two follicles (box and arrow). (F) High-power view of PrPd in the area outlined
by the box in panel E. Note the punctate staining located between the lymphocytes of the follicle. Bars: A, 500 m; C and E, 200 m; B,
D, and F, 50 m.
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being an entry point for neuroinvasion. Alternatively, some of
the infectious agent may have been swallowed after passing
through the nasopharynx and reached the gut to accumulate in
the Peyer’s patches at these later time points. The relatively
late appearance of PrPd in the tongue (70% of the incubation
period) indicates that the agent did not enter the CNS via the
nerves that innervate this structure but were transported cen-
trifugally from the infected brainstem to the tongue, as has
been reported previously (11).
Whether neuroinvasion in this model of prion infection
occurs via direct innervation of the NALT (30, 47) (Fig. 3C),
the sympathetic fibers that innervate lymph nodes and
spleen (15, 16, 20, 21), the well-documented innervation of
the Peyer’s patches (6, 34), or some combination of these
structures remains to be determined. Other potential routes
of entry from the nasal cavity to the CNS include the tri-
geminal and parasympathetic innervation of nasal cavity
structures (14).
Although there has not been a documented case of nat-
ural transmission via the nasal cavity to date, sheep, deer,
and elk possess lymphoid tissue in their nasopharynx (re-
ferred to as either NALT or pharyngeal tonsils), and these
species transmit the TSE agent horizontally between ani-
mals within a herd (9, 12, 23, 37, 38, 49). Support for the
nasal cavity as a potential natural route of entry includes the
finding that lymphoid follicles in the nasal septum of free-
ranging and captive mule deer that were dying of chronic
wasting disease contained the proteinase-resistant isoform
of the prion protein (48) and the recent report that NALT
can support prion accumulation after i.c. inoculation (11).
FIG. 5. PrPd in the spleen and Peyer’s patches after e.n. inoculation. (A) PrPd is restricted to a single lymphoid follicle in the white pulp of the
spleen of a hamster 14 weeks after e.n. inoculation. (B) High-power view of the area outlined in the box in panel A. PrPd is in, or on, cells and
cell processes located between the lymphocytes. (C) PrPd in a Peyer’s patch from a hamster 20 weeks after e.n. inoculation. (D) High-power view
of the area outlined in the box in panel C. PrPd is in, or on, cells and cell processes located between the lymphocytes. Bars: A, 200 m; B, 50 m;
C, 100 m; D, 25 m.
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Thus, in addition to neuroinvasion after experimental expo-
sure to abraded tongue (4) and skin (50), to intact gut
epithelium (5, 7, 27), and to conjunctiva (44), prions may
efficiently enter the CNS and cause disease following expo-
sure to the intact nasal cavity.
ACKNOWLEDGMENTS
This study was supported by the National Center for Research
Resources (P20-RR0115635-6) and by revenue from the Nebraska
Tobacco Settlement awarded to Creighton University by the State of
Nebraska.
The content of this study is solely the responsibility of the authors
and does not necessarily represent the official views of the State of
Nebraska.
We thank Rachel Rhatigan, Maria Christensen, and Meghan Shee-
han for excellent technical assistance with this rather long project.
REFERENCES
1. Andreoletti, O., P. Berthon, E. Levavasseur, D. Marc, F. Lantier, E. Monks,
J.-M. Elsen, and F. Schelcher. 2002. Phenotyping of protein-prion (PrPsc)-
accumulating cells in lymphoid and neural tissues of naturally scrapie-af-
fected sheep by double-labeling immunohistochemistry. J. Histochem. Cy-
tochem. 50:1357–1370.
2. Andreoletti, O., P. Berthon, D. Marc, P. Sarradin, J. Grosclaude, L. van
Keulen, F. Schelcher, J.-M. Elsen, and F. Lantier. 2000. Early accumulation
of PrPsc in gut-associated lymphoid and nervous tissues of susceptible sheep
from a Romanov flock with natural scrapie. J. Gen. Virol. 81:3115–3126.
3. Bartz, J. C., A. E. Kincaid, and R. A. Bessen. 2002. Retrograde transport of
transmissible mink encephalopathy within descending motor tracts. J. Virol.
76:5759–5768.
4. Bartz, J. C., A. E. Kincaid, and R. A. Bessen. 2003. Rapid prion neuroinva-
sion following tongue infection. J. Virol. 77:583–591.
5. Beekes, M., E. Baladuf, and H. Diringer. 1996. Sequential appearance and
accumulation of pathognomonic markers in the central nervous system of
hamsters orally infected with scrapie. J. Gen. Virol. 77:1925–1934.
6. Beekes, M., and P. A. McBride. 2000. Early accumulation of pathological PrP
in the enteric nervous system and gut-associated lymphoid tissue of hamsters
orally infected with scrapie. Neurosci. Lett. 278:181–184.
7. Beekes, M., P. A. McBride, and E. Baladuf. 1998. Cerebral targeting indi-
cates vagal spread of infection in hamster fed orally with scrapie. J. Gen.
Virol. 79:601–607.
8. Blattler, T., S. Brandner, A. J. Raeber, M. A. Klein, T. Voigtlander, C.
Weissmann, and A. Aguzzi. 1997. PrP-expressing tissue required for transfer
of scrapie infectivity from spleen to brain. Nature 389:69–73.
9. Chen, W., M. R. Alley, and B. W. Manktelow. 1989. Respiratory tract-
associated lymphoid tissue in conventionally raised sheep. J. Comp. Pathol.
101:327–340.
10. Collee, J. G., and R. Bradley. 1997. BSE: a decade on-part 1. Lancet 349:
636–642.
11. DeJoia, C., B. Moreaux, K. O. O’Connell, and R. A. Bessen. 2006. Prion
infection of oral and nasal mucosa. J. Virol. 80:4546–4556.
12. Dyce, K. M., W. O. Sack, and C. J. G. Wensing. 1996. The head and ventral
neck of ruminants, p. 631–652. In Textbook of veterinary anatomy, 2nd ed.
The W. B. Saunders Co., Philadelphia, PA.
13. Eklund, C. M., W. J. Hadlow, and R. C. Kennedy. 1963. Some properties of
the scrapie agent and its behavior in mice. Proc. Soc. Exp. Biol. Med.
112:974–979.
14. Farbman, A. I. 1992. Structure of olfactory mucous membrane, p. 24–74. In
Cell biology of olfaction. Cambridge University Press, Cambridge, England.
15. Felten, D. L., K. D. Ackerman, S. J. Wiegand, and S. Y. Felten. 1987.
Noradrenergic sympathetic innervation of the spleen: 1. Nerve fibers asso-
ciate with lymphocytes and macrophages in specific compartments of the
splenic white pulp. J. Neurosci. Res. 18:28–36.
16. Felten, D. L., S. Livnant, S. Y. Felten, S. L. Carlson, D. L. Bellinger, and P.
Yeh. 1984. Sympathetic innervation of lymph nodes in mice. Brain Res. Bull.
13:693–699.
17. Ford, M. J., L. J. Burton, R. J. Morris, and S. M. Hall. 2002. Selective
expression of prion protein in peripheral tissues of the adult mouse. Neu-
roscience 113:177–192.
18. Gajdusek, D. C. 1997. Unconventional viruses and the origin and disappear-
ance of kuru. Science 197:943–960.
19. Giannasca, P. J., J. A. Boden, and T. P. Monath. 1997. Targeted delivery of
antigen to hamster nasal lymphoid tissue with M-cell directed lectins. Infect.
Immun. 65:4288–4298.
20. Glatzel, M., F. L. Heppner, K. M. Albers, and A. Aguzzi. 2001. Sympathetic
innervation of lymphoid organs is rate limiting for prion neuroinvasion.
Neuron 31:25–34.
21. Heggebo, R., L. Gonzalez, C. M. Press, G. Gunnes, A. Espenes, and M.
Jeffrey. 2003. Disease-associated PrP in the enteric nervous system of
scrapie-affected Suffolk sheep. J. Gen. Virol. 84:1327–1338.
22. Heritage, P. L., B. J. Underdown, A. L. Arsenault, D. P. Snider, and M. R.
McDermott. 1997. Comparison of murine nasal-associated lymphoid tissue
and Peyer’s patches. Am. J. Respir. Crit. Care Med. 156:1256–1262.
23. Hunter, N. 2003. Scrapie and experimental BSE in sheep. Br. Med. Bull.
66:171–183.
24. Jeffrey, M., G. McGovern, C. M. Goodsir, K. L. Brown, and M. E. Bruce.
2000. Sites of prion protein accumulation in scrapie-infected mouse spleen
revealed by immuno-electron microscopy. J. Pathol. 191:323–332.
25. Johnson, C. J., K. E. Phillips, P. T. Schramm, D. McKenzie, J. M. Aiken, and
J. A. Pedersen. 2006. Prions adhere to soil minerals and remain infectious.
PLoS Pathog. 2:296–302.
26. Kimberlin, R. H., and C. A. Walker. 1979. Pathogenesis of mouse scrapie:
dynamics of agent replication in spleen, spinal cord and brain after infection
by different routes. J. Comp. Pathol. 89:551–562.
27. Kimberlin, R. H., and C. A. Walker. 1989. Pathogenesis of scrapie in mice
after intragastric infection. Virus. Res. 12:213–220.
28. Kitamoto, T., T. Muramoto, S. Mohri, K. Doh-Ura, and J. Tateishi. 1991.
Abnormal isoform of prion protein accumulates in follicular dendritic cells in
mice with Creutzfeldt-Jakob disease. J. Virol. 65:6292–6295.
29. Kraal, G. 2005. Nasal-associated lymphoid tissue, p. 415–422. In J. Mestecky,
M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer (ed.),
Mucosal immunology, 3rd ed., vol. 1. Elsevier Academic Press, London,
England.
30. Kuper, C. F., D. M. H. Hameleers, J. P. Bruijntjes, I. van der Ven, J.
Biewenga, and T. Sminia. 1990. Lymphoid and non-lymphoid cells in nasal-
associated lymphoid tissue (NALT) in the rat. Cell Tissue Res. 259:371–377.
31. Kuper, C. F., P. J. Koornstra, D. M. H. Hameleers, J. Biewenga, B. J. Spit,
A. M. Duijvestijn, P. J. C. van Breda Vriesman, and T. Sminia. 1992. The
role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219–224.
32. Mabbott, N. A., and G. G. MacPherson. 2006. Prions and their lethal journey
to the brain. Nat. Rev. Microbiol. 4:201–211.
33. Mathiason, C. K., J. G. Powers, S. J. Dahmes, D. A. Osborn, K. V. Miller,
R. J. Warren, G. L. Mason, S. A. Hays, J. Hayes-Klug, D. M. Seelig, M. A.
Wild, L. L. Wolfe, T. R. Spraker, M. W. Miller, C. J. Sigurdson, G. C. Telling,
and E. A. Hoover. 2006. Infectious prions in the saliva and blood of deer with
chronic wasting disease. Science 314:133–136.
34. McBride, P. A., and M. Beekes. 1999. Pathological PrP is abundant in
sympathetic and sensory ganglia of hamsters fed with scrapie. Neurosci. Lett.
265:135–138.
35. McBride, P. A., P. Eikelenboom, G. Kraal, H. Fraser, and M. E. Bruce. 1992.
PrP protein is associated with follicular dendritic cells of spleens and lymph
nodes in uninfected and scrapie-infected mice. J. Pathol. 168:413–418.
36. McBride, P. A., W. J. Schulz-Schaeffer, M. Donaldson, M. Bruce, H. Dir-
inger, H. A. Kretzschmar, and M. Beekes. 2001. Early spread of scrapie from
the gastrointestinal tract to the central nervous system involves autonomic
fibers of the splanchnic and vagus nerves. J. Virol. 75:9320–9327.
37. Miller, M. W., and M. A. Wild. 2004. Epidemiology of chronic wasting
disease in captive white-tailed deer and mule deer. J. Wild. Dis. 40:320–327.
38. Miller, M. W., and E. S. Williams. 2003. Horizontal prion transmission in
mule deer. Nature 425:35–36.
39. Miller, M. W., E. S. Williams, N. T. Hobbs, and L. L. Wolfe. 2004. Environ-
mental sources of prion transmission in mule deer. Emerg. Infect. Dis.
10:1003–1006.
40. Miotti, V. 1961. Die lymphknoten und lymphgefasse des syrischen goldham-
sters. Acta Anat. 46:192–216.
41. National Research Council. 1996. Guide for the care and use of laboratory
animals. National Academy Press, Washington, DC.
42. Race, R., A. Jenny, and D. Sutton. 1998. Scrapie infectivity and proteinase
K-resistant prion protein in sheep placenta, brain, spleen, and lymph node:
implication for transmission and antemortem diagnosis. J. Infect. Dis. 178:
949–953.
43. Scott, J. R., D. Davies, and H. Fraser. 1992. Scrapie in the central nervous
system: neuroanatomical spread of infection and Sinc control of pathogen-
esis. J. Gen. Virol. 73:1637–1644.
44. Scott, J. R., J. D. Foster, and H. Fraser. 1993. Conjunctival instillation of
scrapie in mice can produce disease. Vet. Microbiol. 34:305–309.
45. Seeger, H., M. Heikenwalder, N. Zeller, J. Kranich, P. Schwarz, A. Gaspert,
B. Seifert, G. Miele, and A. Aguzzi. 2005. Coincident scrapie infection and
nephritis lead to urinary prion excretion. Science 310:324–326.
46. Sigurdson, C. J., C. Barillas-Mury, M. W. Miller, B. Oesch, L. J. M. van
Keulen, J. P. M. Langeveld, and E. A. Hoover. 2002. PrPCWD lymphoid cell
targets in early and advanced chronic wasting disease of mule deer. J. Gen.
Virol. 83:2617–2628.
47. Spit, B. J., E. G. J. Hendriksen, J. P. Bruijntes, and C. F. Kuper. 1989. Nasal
lymphoid tissue in the rat. Cell Tissue Res. 255:193–198.
48. Spraker, T. R., R. R. Zink, B. A. Cummings, M. A. Wild, M. W. Miller, and
K. I. O’Rourke. 2002. Comparison of histological lesions and immunohisto-
chemical staining of proteinase-resistant prion protein in a naturally occur-
ring spongiform encephalopathy of free-ranging mule deer (Odocoileus
4490 KINCAID AND BARTZ J. VIROL.
 
hemionus) with those of chronic wasting disease of captive mule deer. Vet.
Pathol. 39:110–119.
49. Stanley, A. C., J. F. Huntley, M. Jeffrey, and D. Buxton. 2001. Characteriza-
tion of ovine nasal-associated lymphoid tissue and identification of M cells in
the overlying follicle-associated epithelium. J. Comp. Pathol. 125:262–270.
50. Taylor, D. M., I. McConnell, and H. Fraser. 1996. Scrapie infection can be
established readily through skin scarification in immunocompetent but not
immunodeficient mice. J. Gen. Virol. 77:1595–1599.
51. Uraih, L. C., and R. R. Maronpot. 1990. Normal histology of the nasal cavity
and application of special techniques. Environ. Health Perspect. 85:187–208.
52. Van Keulen, L. J. M., B. E. C. Schreuder, R. H. Meloen, G. Mooij-Harkes,
M. E. W. Vromans, and J. P. M. Langeveld. 1996. Immunohistochemical
detection of prion protein in lymphoid tissues of sheep with natural scrapie.
J. Clin. Microbiol. 34:1228–1231.
53. Williams, E. S., and S. Young. 1993. Neuropathology of chronic wasting
disease of mule deer (Odocoileus hemionus) and elk (Cervus elaphus nelsoni).
Vet. Pathol. 30:36–45.
54. Zanusso, G., S. Ferrari, F. Cardone, P. Zampieri, M. Gelati, M. Fiorini, A.
Farinazzo, M. Gardiman, T. Cavallaro, M. Bentivoglio, P. G. Righetti, M.
Pocchiari, N. Rizzuto, and S. Monaco. 2003. Detection of pathologic prion
protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease.
N. Engl. J. Med. 348:711–719.
VOL. 81, 2007 PRION INFECTION VIA THE NASAL CAVITY 4491
 
